title: Tamsulosin and nifedipine did not improve stone passage over placebo nor were they cost-effective in ureteric stone disease.
authors.affiliation: Department of Renal Medicine, Salford Royal NHS Foundation Trust, Salford, UK.
authors.forename: Sayyid M Ammar
authors.initials: SM
authors.lastname: Raza
authors.affiliation: Department of Renal Medicine, Salford Royal NHS Foundation Trust, Salford, UK.
authors.forename: Philip A
authors.initials: PA
authors.lastname: Kalra
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009543:Nifedipine / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D014545:Urinary Calculi / Q000188:drug therapy*
chemical_list: D058668:Adrenergic alpha-1 Receptor Antagonists; D002121:Calcium Channel Blockers; D013449:Sulfonamides; D009543:Nifedipine